Search Query :
4C37
Pka-s6k1 chimera with compound 21a (cct196539) bound Deposition Author(s): Aherne, G.W. , Barillari, C. , Boxall, K. , Burns, S. , Cano, C. , Chow, C.L. , Clarke, P.A. , Couty, S. , Griffin, R.J. , Jones, K. , Kalusa, A. , Linardopoulos, S. , Mcandrew, P.C. , Pickard, L. , Raynaud, F.I. , Schmitt, J. , Travers, J. , Van Montfort, R.L.M. , Westwood, I.M. , Workman, P.
Date: 2013-08-21 Method: X-RAY DIFFRACTION Resolution: 1.7 Å Organism(s): Bos Taurus , Synthetic Construct Sequences Data: 4C37_A , 4C37_I
4C38
Pka-s6k1 chimera with compound 21e (cct239066) bound Deposition Author(s): Aherne, G.W. , Barillari, C. , Boxall, K. , Burns, S. , Cano, C. , Chow, C.L. , Clarke, P.A. , Couty, S. , Griffin, R.J. , Jones, K. , Kalusa, A. , Linardopoulos, S. , Mcandrew, P.C. , Pickard, L. , Raynaud, F.I. , Schmitt, J. , Travers, J. , Van Montfort, R.L.M. , Westwood, I.M. , Workman, P.
Date: 2013-08-21 Method: X-RAY DIFFRACTION Resolution: 1.58 Å Organism(s): Bos Taurus , Synthetic Construct Sequences Data: 4C38_A , 4C38_I
4C4E
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1 Deposition Author(s): Atrash, B. , Baker, R. , Bavetsias, V. , Blagg, J. , Boxall, K. , Burke, R. , Choi, V. , De Haven Brandon, A. , Eccles, S.A. , Faisal, A. , Gurden, M. , Hayes, A. , Henley, A. , Linardopoulos, S. , Liu, M. , Mak, G. , Matijssen, B. , Mcandrew, C. , Naud, S. , Raynaud, F.I. , Schmitt, J. , Sheldrake, P. , Valenti, M. , Van Montfort, R. , Westwood, I.M. , Wood, A.
Date: 2013-09-05 Method: X-RAY DIFFRACTION Resolution: 2.6 Å Organism(s): Homo Sapiens Sequences Data: 4C4E_A
4C4F
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1 Deposition Author(s): Atrash, B. , Baker, R. , Bavetsias, V. , Blagg, J. , Boxall, K. , Burke, R. , Choi, V. , De Haven Brandon, A. , Eccles, S.A. , Faisal, A. , Gurden, M. , Hayes, A. , Henley, A. , Linardopoulos, S. , Liu, M. , Mak, G. , Matijssen, B. , Mcandrew, C. , Naud, S. , Raynaud, F.I. , Schmitt, J. , Sheldrake, P. , Valenti, M. , Van Montfort, R. , Westwood, I.M. , Wood, A.
Date: 2013-09-05 Method: X-RAY DIFFRACTION Resolution: 2.36 Å Organism(s): Homo Sapiens Sequences Data: 4C4F_A
4C4G
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1 Deposition Author(s): Atrash, B. , Baker, R. , Bavetsias, V. , Blagg, J. , Boxall, K. , Burke, R. , Choi, V. , De Haven Brandon, A. , Eccles, S.A. , Faisal, A. , Gurden, M. , Hayes, A. , Henley, A. , Linardopoulos, S. , Liu, M. , Mak, G. , Matijssen, B. , Mcandrew, C. , Naud, S. , Raynaud, F.I. , Schmitt, J. , Sheldrake, P. , Valenti, M. , Van Montfort, R. , Westwood, I.M. , Wood, A.
Date: 2013-09-05 Method: X-RAY DIFFRACTION Resolution: 2.65 Å Organism(s): Homo Sapiens Sequences Data: 4C4G_A
4C4H
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1 Deposition Author(s): Atrash, B. , Baker, R. , Bavetsias, V. , Blagg, J. , Boxall, K. , Burke, R. , Choi, V. , De Haven Brandon, A. , Eccles, S.A. , Faisal, A. , Gurden, M. , Hayes, A. , Henley, A. , Linardopoulos, S. , Liu, M. , Mak, G. , Matijssen, B. , Mcandrew, C. , Naud, S. , Raynaud, F.I. , Schmitt, J. , Sheldrake, P. , Valenti, M. , Van Montfort, R. , Westwood, I.M. , Wood, A.
Date: 2013-09-05 Method: X-RAY DIFFRACTION Resolution: 2.8 Å Organism(s): Homo Sapiens Sequences Data: 4C4H_A
4C4I
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1 Deposition Author(s): Atrash, B. , Baker, R. , Bavetsias, V. , Blagg, J. , Boxall, K. , Burke, R. , Choi, V. , De Haven Brandon, A. , Eccles, S.A. , Faisal, A. , Gurden, M. , Hayes, A. , Henley, A. , Linardopoulos, S. , Liu, M. , Mak, G. , Matijssen, B. , Mcandrew, C. , Naud, S. , Raynaud, F.I. , Schmitt, J. , Sheldrake, P. , Valenti, M. , Van Montfort, R. , Westwood, I.M. , Wood, A.
Date: 2013-09-05 Method: X-RAY DIFFRACTION Resolution: 2.65 Å Organism(s): Homo Sapiens Sequences Data: 4C4I_A
4C4J
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1 Deposition Author(s): Atrash, B. , Baker, R. , Bavetsias, V. , Blagg, J. , Boxall, K. , Burke, R. , Choi, V. , De Haven Brandon, A. , Eccles, S.A. , Faisal, A. , Gurden, M. , Hayes, A. , Henley, A. , Linardopoulos, S. , Liu, M. , Mak, G. , Matijssen, B. , Mcandrew, C. , Naud, S. , Raynaud, F.I. , Schmitt, J. , Sheldrake, P. , Valenti, M. , Van Montfort, R. , Westwood, I.M. , Wood, A.
Date: 2013-09-05 Method: X-RAY DIFFRACTION Resolution: 2.5 Å Organism(s): Homo Sapiens Sequences Data: 4C4J_A
5F4N
Multi-parameter lead optimization to give an oral chk1 inhibitor clinical candidate: (r)-5-((4-((morpholin-2-ylmethyl)amino)-5-(trifluoromethyl)pyridin-2-yl)amino)pyrazine-2-carbonitrile (cct245737) Deposition Author(s): Aherne, G.W. , Box, G. , Boxall, K.J. , Brown, N. , Cheung, K.J. , Collins, I. , De Haven Brandon, A.K. , Eccles, S.A. , Eve, P.D. , Garrett, M.D. , Hayes, A. , Henley, A.T. , Jamin, Y. , Lainchbury, M. , Leonard, P. , Matthews, T.P. , Mchardy, T. , Osborne, J.D. , Proisy, N. , Raynaud, F.I. , Reader, J.C. , Robinson, S.P. , Valenti, M.R. , Van Montfort, R. , Walton, M.I. , Westwood, I.M.
Date: 2015-12-03 Method: X-RAY DIFFRACTION Resolution: 1.91 Å Organism(s): N.A. Sequences Data: 5F4N_A